What laboratory tests should I order to evaluate thyroid function, including T4 and T3, in a patient with suspected hypo‑ or hyperthyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Testing for Thyroid Function Evaluation

Order TSH as your initial screening test, and if abnormal, follow with free T4 to distinguish between subclinical and overt thyroid dysfunction. 1, 2

Initial Testing Strategy

First-Line Test: TSH

  • TSH is the most sensitive initial screening test with sensitivity above 98% and specificity greater than 92% for detecting thyroid dysfunction 2, 3
  • TSH testing using monoclonal antibodies is the recommended first test for screening and evaluating patients with symptomatic thyroid disease 1
  • A single TSH measurement effectively identifies both hypo- and hyperthyroidism in most uncomplicated cases 4, 3

Second-Line Test: Free T4

  • Measure free T4 (FT4) when TSH is abnormal to distinguish between subclinical hypothyroidism (normal FT4) and overt hypothyroidism (low FT4) 2, 3
  • Free T4 provides a more accurate assessment than total T4 because it is not influenced by variations in thyroid hormone-binding proteins 5, 6
  • In pregnant women with suspected thyroid dysfunction, measure both TSH and FT4 or free thyroxine index (FTI) together 1

When to Add T3 Testing

Limited Indications for T3

  • Measure free T3 (FT3) only in specific scenarios:
    • When TSH is suppressed but free T4 is normal, to detect T3 toxicosis 4, 3
    • When hyperthyroidism is suspected but FT4 is normal 5
    • For early diagnosis of hyperthyroidism 7

T3 Is NOT Useful for Hypothyroidism

  • Do not routinely measure T3 when evaluating suspected hypothyroidism because FT3 may remain normal even in patients with subclinical or mild thyroid failure 6
  • Serum T3 is not useful for verification of clinical hypothyroidism 7
  • Circulating T3 is a less reliable reflection of thyroid hormone production than T4 because 80% is produced extrathyroidally from T4 deiodination 5

Algorithmic Approach

For Suspected Hypothyroidism:

  1. Order TSH first 1, 2, 3
  2. If TSH is elevated: Add free T4 to distinguish subclinical (normal FT4) from overt (low FT4) hypothyroidism 2, 3
  3. If TSH is normal but clinical suspicion remains high: Consider central hypothyroidism and measure free T4 directly 3
  4. Do NOT order T3 for hypothyroidism evaluation 7, 6

For Suspected Hyperthyroidism:

  1. Order TSH first 1, 4
  2. If TSH is suppressed: Add free T4 4, 3
  3. If TSH is suppressed but FT4 is normal: Add free T3 to detect T3 toxicosis 4, 3

Common Pitfalls to Avoid

  • Avoid ordering total T4 or total T3 instead of free hormones, as total hormone measurements are influenced by binding protein abnormalities (pregnancy, estrogen therapy, familial dysalbuminemic hyperthyroxinemia, TBG deficiency) 5, 6
  • Do not order T3 when evaluating hypothyroidism—it adds no diagnostic value and may remain normal despite significant thyroid failure 7, 6
  • Recognize that thyroid tests are often abnormal in non-thyroidal illnesses and drug administration can affect results; interpret cautiously in hospitalized or acutely ill patients 7, 5
  • Confirm elevated TSH with repeat testing after 3–6 weeks before initiating treatment, as 30–60% of elevated TSH values normalize spontaneously 2

Special Populations

Pregnancy

  • Measure both TSH and FT4 (or FTI) together in pregnant women with suspected thyroid dysfunction 1
  • TSH and FT4 should be performed in pregnant women with suspected hyperthyroidism or hypothyroidism 1

Central Hypothyroidism

  • When pituitary or hypothalamic disease is suspected, TSH cannot be used as a screening test—measure free T4 and free T3 directly 3
  • TSH may be inappropriately normal or even low despite low thyroid hormone levels in central hypothyroidism 3

Monitoring Thyroid Replacement

  • For primary hypothyroidism on treatment: TSH is the most important parameter to monitor 3
  • For central hypothyroidism on treatment: Use free T4 and T3 concentrations because TSH levels cannot be used 3

References

Related Questions

What does a free thyroxine (free T4) level of 0.89 ng/dL and thyroid‑stimulating hormone (TSH) level of 1.38 µIU/mL indicate about thyroid function and the need for treatment?
What labs are used to diagnose secondary hypothyroidism?
When should free T3 (FT3) be measured instead of total T3 (TT3), and what are the differences between them?
What are the normal lab values for Thyroid Stimulating Hormone (TSH), free Triiodothyronine (T3), and free Thyroxine (T4) and how do you interpret them to diagnose hyperthyroidism and hypothyroidism.
What does a Thyroid-Stimulating Hormone (TSH) level with reflex Thyroxine (T4) test indicate about thyroid function in a patient?
How should I manage an adult patient with elevated serum pyridoxal‑5′‑phosphate from excessive pyridoxine supplementation (>100 mg/day) who presents with sensory neuropathy, especially if they have chronic kidney disease, diabetes, or alcohol use disorder?
Can a patient with rheumatoid arthritis be maintained on daily prednisone 2.5 mg as part of management?
Should a patient with multiple sclerosis and digestive symptoms be treated with Creon (pancrelipase), and what initial dose is appropriate?
What is the recommended regimen to transition a patient who is clinically stable on haloperidol decanoate 200 mg IM monthly to paliperidone palmitate (Invega Sustenna), including loading doses, injection site considerations, and monitoring for contraindications and side effects?
How should I manage a patient presenting with vertigo, mild left‑sided chest pain, and abdominal distention?
What is the recommended Brilinta (ticagrelor) dosing regimen after percutaneous coronary intervention, including loading dose, maintenance dose, adjustments for patients aged ≥ 75 years, weighing ≤ 60 kg, or with moderate renal impairment, and the advised duration of therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.